The U.S. Food and Drug Administration has warned the pharmaceutical company Sanofi about significant deviations from Current Good Manufacturing Practice for active pharmaceutical ingredients at their ...
The owners of 3 Idlewile Lane in Weston admired a home they saw in Architectural Digest, so they purchased over eight acres ...
Sisitsky submitted his plan to comply with the law late last month after city councilors voted to table discussing the issue ...
Good morning! Here are the five things you need to know in local business news to start your busy — and still very cold — ...
The criminal defendants in the more than 30,000 Massachusetts drug cases that were tossed due to the tampering chemists Annie ...
The FDA issued a warning letter to Sanofi regarding significant manufacturing violations at its Genzyme Corporation Facility in Framingham, Mass. The letter, dated Dec. 16, 2024, and amended Jan. 15, ...
The FDA has warned Sanofi about a series of “significant” manufacturing problems, including contamination, at a key facility ...
A new FDA warning letter for French pharmaceutical company Sanofi cited a handful of issues at its biologics factory in ...
Despite receiving a prior wrist slap from the FDA in the shape of a Form 483, Sanofi is still working to right the ship at a ...
Terry Hodge would have a tough time caring for the 150 or so elderly women at Bethany Health Care Center without the dozens of immigrant nursing assistants, housekeepers, dietary aides and other ...
Manufacturers who use Red No. 3 in food will have until Jan. 15, 2027, to reformulate their products now that the FDA has ...
The SJC decision will have ramifications for municipalities that have rejected proposed zoning rules as outlined in the MBTA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback